ArticleNeurological research and practice2021
Acute ischemic stroke care in Germany - further progress from 2016 to 2019.
Article in Neurological research and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 39 citations in OpenAlex.
- Delayed Care in Self-Presenting Stroke Patients: Real-World Data on Process Delays-Comparing Process Times Between Emergency Medical Services and Self-Presentation.Journal of clinical medicine · 2026Article
- Challenges and solutions in determining urolithiasis caseloads using the digital infrastructure of a clinical data warehouse.PloS one · 2026Article
- Acute Ischemic Stroke Treatment in Germany (2015-2023): Nationwide Trends in Thrombolysis and Thrombectomy by Age and Sex.Brain sciences · 2025Article
- Trends in acute care of cerebrovascular events- a joinpoint analysis with German hospital data from 2000 to 2021.Neurological research and practice · 2025Article
- Impact of academic center for evidence-based practice star model on door-to-needle times in patients with acute ischemic stroke.Pakistan journal of medical sciences · 2025Article
- No disadvantages for women in acute stroke care in Germany: an analysis of access to stroke treatment services in Germany from 2017 to 2022.Neurological research and practice · 2025Article
- Becoming a thrombectomy-capable stroke center: Clinical and medico-economical effectiveness at the hospital level.European stroke journal · 2024Article
- Support by telestroke networks is associated with increased intravenous thrombolysis and reduced hospital transfers: A german claims data analysis.Health economics review · 2024Review
- Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry.Journal of Korean medical science · 2024Review
- FAST4D-A New Score to Reduce Missed Strokes in Emergency Medical Service: A Prospective, Multicentric Observational Proof-of-Concept Trial.Journal of clinical medicine · 2024Article
- Variation in US acute ischemic stroke treatment by hospital regions: limited endovascular access despite evidence.Journal of neurointerventional surgery · 2024Article
- The evolution of acute stroke care in Germany from 2019 to 2021: analysis of nation-wide administrative datasets.Neurological research and practice · 2024Article
- Milestones in the history of neurocritical care.Neurological research and practice · 2023Review
- Brain alarm by self-extracellular nucleic acids: from neuroinflammation to neurodegeneration.Journal of biomedical science · 2023Review
- A deep learning analysis of stroke onset time prediction and comparison to DWI-FLAIR mismatch.NeuroImage. Clinical · 2023Article
- Improving the Prognosis of Patients With Acute Ischemic Stroke Treated in the Late Time Window After the Introduction of Advanced Imaging Software: Benefits From Thrombectomy in the Extended Time Window.Journal of Korean medical science · 2022Article
- Mechanical Thrombectomy in Patients with Acute Ischemic Stroke and Concomitant Intracranial Hemorrhage.Clinical neuroradiology · 2022Article
- Did the severity of the COVID-19 outbreak affect the quality of acute stroke care? (Data from across the country).European stroke journal · 2022Article
- Rates of intravenous thrombolysis and endovascular therapy for acute ischaemic stroke in China between 2019 and 2020.The Lancet regional health. Western Pacific · 2022Article
- A full year of the COVID-19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany.European journal of neurology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStroke Unit Care (SUC), intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are evidence-based treatment options for acute ischemic stroke (AIS). Using nationwide comprehensive administrative data from Germany, we recently reported nationwide development of AIS admissions, SUC rates, IVT rates and MT rates in Germany between 2010 and 2016. In this update paper, we analyze data on the further development of these data to 2019 after publication of time window extensions for recanalization therapies.
methodsWe considered all hospitalized cases with the main diagnosis of the ICD-10-GM code I63 (AIS) for the year 2019. We identified stroke therapies by using the corresponding Operating and Procedure Keys for IVT, MT and SUC out of the DRG statistics. Regional analyses are based on data from the 412 German administrative districts and cities. We compared the results with those from 2016.
resultsNumber of hospitalized AIS patients showed a mild decrease in 2019 (n = 225,531) compared with 2016 (n = 227,687), with significant more AIS patients treated on a stroke unit in 2019 (n = 167,799; 74.4% vs. n = 164,270; 72.1%, p < 0.001). The rate of IVT further increased from 14.9% (n = 33,916) in 2016 to 16.3% (n = 36,745) in 2019 (p < 0.001). Similarly, the MT rate increased from 4.3% (n = 9795) in 2016 to 7.2% (n = 16,135) in 2019 (p < 0.001). There was still a high regional variability for MT (1.4 to 15.2%) according to the place of residence of the AIS patients.
conclusionsIn Germany, the rates of recanalization therapies in patients with AIS continued to increase from 2016 to 2019. Compared to IVT-rates and numbers, the respective data for MT procedures showed an even more pronounced increase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.